Infinity Pharmaceuticals, Inc.

INFIQ · OTC
Analyze with AI
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Operating Activities
Net Income-$44,369-$45,262-$40,492-$47,057
Dep. & Amort.$458$480$483$219
Deferred Tax$0$0$0$0
Stock-Based Comp.$3,621$2,695$1,456$2,133
Change in WC-$1,039$2,214$1,385$1,383
Other Non-Cash-$1,102-$745$1,429$1,792
Operating Cash Flow-$42,431-$40,618-$35,739-$41,530
Investing Activities
PP&E Inv.-$17-$11-$43-$2,327
Net Acquisitions$0$0$0$0
Inv. Purchases-$16,038$0-$43,006-$41,864
Inv. Sales/Matur.$16,000$5,500$57,680$31,950
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$55$5,489$14,631-$12,241
Financing Activities
Debt Repay.$0$0$19,572$0
Stock Issued$73$87,105$7,869$112
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$27,618
Financing Cash Flow$73$87,105$27,441$27,730
Forex Effect$0$0$0$0
Net Chg. in Cash-$42,413$51,976$6,333-$26,041
Supplemental Information
Beg. Cash$80,884$28,908$22,575$48,616
End Cash$38,471$80,884$28,908$22,575
Free Cash Flow-$42,448-$40,629-$35,782-$43,857